L.‐C. Chu
Impact in
- Physiology top 2%
- Adenosine and Purinergic Signaling
- Nitric Oxide and Endothelin Effects
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
Papers in
-
- Biochemical and Molecular Research 3
- Enzyme function and inhibition 2
-
- Analytical Methods in Pharmaceuticals 5
- Co-authors
- Thomas P. Zimmerman (5 shared papers)P Imhof (4 shared papers)Gerald Wolberg (1 shared paper)J Hodler (2 shared papers)Philipp Müller (1 shared paper)W.F. Bayne (4 shared papers)F Burkart (1 shared paper)A. Gérardin (1 shared paper)
- Journals
- Journal of Pharmaceutical Sciences (4 papers)European Journal of Clinical Pharmacology (3 papers)Biochemical Pharmacology (2 papers)Science (1 paper)Analytical Biochemistry (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
L.‐C. Chu
16 papers receiving 642 citations
Peers
Comparison fields: 5 of 91
- Physiology 168
- Pharmaceutical Science 47
- Cardiology and Cardiovascular Medicine 138
- Physiology 112
- Pharmacology 69
Countries citing papers authored by L.‐C. Chu
This map shows the geographic impact of L.‐C. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.‐C. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.‐C. Chu more than expected).
Fields of papers citing papers by L.‐C. Chu
This network shows the impact of papers produced by L.‐C. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.‐C. Chu. The network helps show where L.‐C. Chu may publish in the future.
Co-authors
The 20 scholars most cited alongside L.‐C. Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1975 | 249 | |
| 2 | 1980 | 130 | |
| 3 | 1982 | 114 | |
| 4 | 1982 | 42 | |
| 5 | Identification of 6-methylmercaptopurine ribonucleoside 5'-diphosphate and 5'-triphosphate as metabolites of 6-mercaptopurine in man. | 1974 | 38 |
| 6 | 1979 | 23 | |
| 7 | 1976 | 22 | |
| 8 | 1979 | 22 | |
| 9 | 1974 | 21 | |
| 10 | 1981 | 21 | |
| 11 | 1976 | 20 | |
| 12 | 1981 | 10 | |
| 13 | 1984 | 8 | |
| 14 | 1974 | 7 | |
| 15 | 1984 | 7 | |
| 16 | 1985 | 2 | |
| 17 | 1984 | 0 |
About L.‐C. Chu
L.‐C. Chu is a scholar working on Molecular Biology, Analytical Chemistry, Infectious Diseases, Cardiology and Cardiovascular Medicine and Organic Chemistry, having authored 17 papers that have together received 736 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), HIV/AIDS drug development and treatment (3 papers), Biochemical and Molecular Research (3 papers), Adenosine and Purinergic Signaling (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Pain Mechanisms and Treatments (2 papers), Anesthesia and Sedative Agents (2 papers) and Enzyme function and inhibition (2 papers). The work is most often cited by research in Physiology (168 citations), Pharmaceutical Science (47 citations), Cardiology and Cardiovascular Medicine (138 citations), Physiology (112 citations) and Pharmacology (69 citations). L.‐C. Chu has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Thomas P. Zimmerman, P Imhof, Gerald Wolberg, J Hodler, Philipp Müller, W.F. Bayne, F Burkart, A. Gérardin, Felix Theeuwes and Gertrude B. Elion. Their work appears in journals such as Journal of Pharmaceutical Sciences, European Journal of Clinical Pharmacology, Biochemical Pharmacology, Science and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.